• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis . Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019

tetano

Editor, Senior Moderator
Clin Infect Dis


. 2020 Nov 21;ciaa1421.
doi: 10.1093/cid/ciaa1421. Online ahead of print.
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019


Jee-Soo Lee[SUP] 1 [/SUP], So Yeon Kim[SUP] 2 [/SUP], Taek Soo Kim[SUP] 1 [/SUP], Ki Ho Hong[SUP] 3 [/SUP], Nam-Hee Ryoo[SUP] 4 [/SUP], Jaehyeon Lee[SUP] 5 [/SUP], Jae Hyeon Park[SUP] 1 [/SUP], Sung Im Cho[SUP] 1 [/SUP], Man Jin Kim[SUP] 1 [/SUP], Young-Gon Kim[SUP] 1 [/SUP], Boram Kim[SUP] 1 [/SUP], Ho Seob Shin[SUP] 1 [/SUP], Hyeon Sae Oh[SUP] 1 [/SUP], Myoung-Seock Seo[SUP] 1 [/SUP], Tae-Rin Gwon[SUP] 1 [/SUP], Yeonjae Kim[SUP] 6 [/SUP], Jun-Sun Park[SUP] 7 [/SUP], Bum Sik Chin[SUP] 6 [/SUP], Wan Beom Park[SUP] 8 [/SUP], Sung Sup Park[SUP] 1 [/SUP], Moon-Woo Seong[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Positive results from real-time reverse-transcription polymerase chain reaction (rRT-PCR) in recovered patients raise concern that patients who recover from coronavirus disease 2019 (COVID-19) may be at risk of reinfection. Currently, however, evidence that supports reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not been reported.
Methods: We conducted whole-genome sequencing of the viral RNA from clinical specimens at the initial infection and at the positive retest from 6 patients who recovered from COVID-19 and retested positive for SARS-CoV-2 via rRT-PCR after recovery. A total of 13 viral RNAs from the patients' respiratory specimens were consecutively obtained, which enabled us to characterize the difference in viral genomes between initial infection and positive retest.
Results: At the time of the positive retest, we were able to acquire a complete genome sequence from patient 1, a 21-year-old previously healthy woman. In this patient, through the phylogenetic analysis, we confirmed that the viral RNA of positive retest was clustered into a subgroup distinct from that of the initial infection, suggesting that there was a reinfection of SARS-CoV-2 with a subtype that was different from that of the primary strain. The spike protein D614G substitution that defines the clade "G" emerged in reinfection, while mutations that characterize the clade "V" (ie, nsp6 L37F and ORF3a G251V) were present at initial infection.
Conclusions: Reinfection with a genetically distinct SARS-CoV-2 strain may occur in an immunocompetent patient shortly after recovery from mild COVID-19. SARS-CoV-2 infection may not confer immunity against a different SARS-CoV-2 strain.

Keywords: COVID-19; SARS-CoV-2; reinfection; whole-genome sequencing.
 
Back
Top Bottom